(Q42273026)

19 October 2017

Glucagon as a critical factor in the pathology of diabetes (English)

1 reference

https://api.crossref.org/works/10.2337/DB10-1594

19 October 2017

Glucagon as a Critical Factor in the Pathology of Diabetes (English)

1 reference

23 November 2024

0 references

1 reference

1

Dale S Edgerton

1 reference

19 October 2017

2

Alan D Cherrington

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

19 October 2017

February 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21270249

full work available at URL

23 November 2024

https://diabetesjournals.org/diabetes/article-pdf/60/2/377/399224/377.pdf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21270249

http://intl-diabetes.diabetesjournals.org/cgi/content/abstract/60/2/377

23 November 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21270249

https://europepmc.org/articles/PMC3028334

23 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21270249

https://europepmc.org/articles/PMC3028334?pdf=render

23 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21270249

https://journals.org/diabetes/diabetes/article-pdf/60/2/377/399224/377.pdf

23 November 2024

1 reference

https://api.crossref.org/works/10.2337/DB10-1594

https://diabetesjournals.org/diabetes/article-pdf/60/2/377/399224/377.pdf

23 November 2024

1 reference

https://api.crossref.org/works/10.2337/DB10-1594

23 November 2024

1 reference

19 October 2017

60

1 reference

19 October 2017

2

1 reference

19 October 2017

377-380

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

19 October 2017

start time

30 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Leptin therapy in insulin-deficient type I diabetes

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Glucagon-mediated impairments in hepatic and peripheral tissue nutrient disposal are not aggravated by increased lipid availability

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

The glucagon receptor is required for the adaptive metabolic response to fasting

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

26 October 2017

Four grams of glucose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Making insulin-deficient type 1 diabetic rodents thrive without insulin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Use of GLUT-4 null mice to study skeletal muscle glucose uptake

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Regulation of hepatic and peripheral glucose disposal

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Glucagon deficiency and hyperaminoacidemia after total pancreatectomy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Kinetics of glucose disposal in whole body and across the forearm in man.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Effect of glucagon on glucose production during insulin deficiency in the dog

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Effect of GLP-1 on glucose transport and its cell signalling in human myocytes.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Cell signalling of the GLP-1 action in rat liver

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Insulin is required for the liver to respond to intraportal glucose delivery in the conscious dog

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3028334

Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus

17 August 2018

1 reference

12 December 2020

Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy

1 reference

12 December 2020

Role of glucagon suppression on gluconeogenesis during insulin treatment of the conscious diabetic dog

1 reference

12 December 2020

Regulation of free fatty acid metabolism by glucagon

1 reference

12 December 2020

Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM

1 reference

12 December 2020

A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

1 reference

12 December 2020

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia

1 reference

12 December 2020

Glucagon chronically impairs hepatic and muscle glucose disposal

1 reference

12 December 2020

Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels

1 reference

12 December 2020

Physiological Levels of Glucagon Do Not Influence Lipolysis in Abdominal Adipose Tissue as Assessed by Microdialysis1

1 reference

12 December 2020

Identifiers

DOI

10.2337/DB10-1594

1 reference

19 October 2017

1 reference

19 October 2017

1 reference